Catalyst Wire Dossier Catalyst Wire Dossier

Topical Minocycline FXFM244

minocycline · Vyne Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Topical Minocycline FXFM244, covering 2013-12-10 to 2015-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients [Phase 2]

See pricing